Literature DB >> 1204275

Quinine-induced alterations in drug disposition.

C M Berlin, J M Stackman, E S Vesell.   

Abstract

In normal volunteers, chronic quinine administration shortened plasma antipyrine half-life and significantly increased the intraindividual correlation between the disposition of quinine and antipyrine. Decreased plasma antipyrine half-life appears to be due to a quinine-induced enhancement of antipyrine metabolism. A dose-dependent prolongation of plasma quinine half-life was observed and attributed primarily to an increased apparent volume of distribution of quinine, although our data did not permit separation of an effect on quinine metabolism from an effect on quinine distribution between the peripheral and central compartments. Plasma protein binding of quinine was similar at both the low and high doses of quinine. Studies in dogs given quinine intravenously revealed a biphasic plasma decay curve compatible with a 2-compartment open model for quinine disposition. Dose dependence of plasma quinine half-life in the dog after intravenous quinine eliminated altered gastrointestinal absorption of quinine as a cause for the dose dependence of plasma quinine half-life. These studies illustrate the importance of such conditions as dose and time of administration in determining the type and magnitude of interaction observed between drugs.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1204275     DOI: 10.1002/cpt1975186670

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  11 in total

1.  Dose-dependence of the pharmacokinetics of quinidine.

Authors:  P Bolme; U Otto
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

2.  Effect of dose size on the pharmacokinetics of orally administered quinine.

Authors:  A Sowunmi; L A Salako
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

Review 3.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

4.  Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.

Authors:  L A Salako; A Sowunmi
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

7.  A quinine a day keeps the leg cramps away?

Authors:  A Warburton; J P Royston; C J O'Neill; P W Nicholson; R D Jee; M J Denham; S M Dobbs; R J Dobbs
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

Review 8.  Clinical features and management of poisoning due to antimalarial drugs.

Authors:  A Jaeger; P Sauder; J Kopferschmitt; F Flesch
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

9.  Disposition of quinine in rats with induced renal failure.

Authors:  C O Onyeji; P A Dixon; N C Ugwu
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

10.  The pharmacokinetics and pharmacodynamics of quinine in the diabetic and non-diabetic elderly.

Authors:  J R Dyer; T M Davis; C Giele; T Annus; P Garcia-Webb; J Robson
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.